相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Time to recognize three classes of non-inferiority trial margins
Jeffrey L. Saver et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)
Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke: A Phase Ila Randomized Clinical Trial
Haiqing Song et al.
TRANSLATIONAL STROKE RESEARCH (2022)
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
Eugene Gusev et al.
LANCET NEUROLOGY (2021)
Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
Huaguang Zheng et al.
STROKE AND VASCULAR NEUROLOGY (2020)
Effect of human recombinant prourokinase(rhpro-UK) on thromboembolic stroke in rats
Chun-hua Hao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2018)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies
Jessica S. Cranston et al.
STROKE (2017)
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Bart M. Demaerschalk et al.
STROKE (2016)
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Philip M. W. Bath et al.
STROKE (2012)
Mutant Prourokinase with Adjunctive C1-Inhibitor Is an Effective and Safer Alternative to tPA in Rat Stroke
Simone Tomasi et al.
PLOS ONE (2011)
Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies
Gregory W. Albers et al.
STROKE (2011)
Thrombolysis with alteplase 3-4•5 h after acute ischaemic stroke (SITS-ISTR):: an observational study
Nils Wahlgren et al.
LANCET (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
R. Pannell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren et al.
LANCET (2007)
分享论文
